Medtronic pays $110M to acquire Aptus Endosystems

Candace Stuart | | Cardiovascular Business | Vascular & Endovascular

Medtronic expanded its reach in the endovascular market with the acquisition of Aptus Endosystems, a company that specializes in advanced technology for endovascular aneurysm repair and thoracic endovascular aneurysm repair.

Medtronic announced that it bought the assets of Aptus for $110 million. It did not disclose other terms of the deal.

Aptus’ products include the Heli-FX EndoAnchor System and Heli-FX Thoracic EndoAnchor System, which complements minimally invasive aneurysm repair by locking an endograft to the aorta or vessel walls. The systems can be used in patients with challenging anatomies and those with complex aortic disease and are compatible with Medtronic’s Endurant and Valiant stent graft systems. Both Heli-FX systems have been cleared by the FDA in the U.S. and have CE mark in Europe.

Aptus also makes the TourGuide Steerable Sheath for delivering peripheral vascular products. The sheath has tip deflection technology for navigating challenging anatomies, which Actus claims reduces the need for using multiple catheters. Medtronic will take over distribution of the sheath in the U.S. and Europe.

Sunnyvale, Calif.-based Actos will join the aortic and peripheral vascular division in Medtronic’s Cardiac and Vascular Group. That group also recently invested in another endovascular technology company with the option to acquire it if milestones are met. The company, AAA Arsenal, develops a foam and delivery catheter for stabilizing aneurysms and reducing the occurrence of endoleaks. Medtronic did not disclose the financial terms of that deal. 

Candace Stuart, Contributor

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."